IMVT

Immunovant, Inc. Common Stock#77 · 2020EPA

Yearly return

+196%

Peak return

+245%

Max drawdown

-55%

ADR (20 days)

+5.8%

Base

13 days / -22.5%

Prior run

+99%

Breakout volume

6.0x

Pivot

$28.56

Catalyst Unternehmensmeldung2020-08-218-K 8-K-Meldung, Immunovant, Inc.SEC EDGAR

Offizielle Unternehmensmitteilung im Umfeld des Ausbruchs. Beleg: offizielles 8-K-Filing bei der SEC.

Materials · Materials/Commodities

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare IMVT with the current market directly.